Champions Oncology, Inc.

NasdaqCM:CSBR 株式レポート

時価総額:US$61.9m

Champions Oncology マネジメント

マネジメント 基準チェック /44

Champions Oncologyの CEO はRonnie Morrisで、 Jan2017年に任命され、 の在任期間は 7.83年です。 の年間総報酬は$ 400.00Kで、 100%給与と0%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の6.32%を直接所有しており、その価値は$ 3.91M 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と13.4年です。

主要情報

Ronnie Morris

最高経営責任者

US$400.0k

報酬総額

CEO給与比率100.0%
CEO在任期間7.8yrs
CEOの所有権6.3%
経営陣の平均在職期間3.8yrs
取締役会の平均在任期間13.4yrs

経営陣の近況

Recent updates

Companies Like Champions Oncology (NASDAQ:CSBR) Can Afford To Invest In Growth

Oct 24
Companies Like Champions Oncology (NASDAQ:CSBR) Can Afford To Invest In Growth

It's A Story Of Risk Vs Reward With Champions Oncology, Inc. (NASDAQ:CSBR)

Jun 14
It's A Story Of Risk Vs Reward With Champions Oncology, Inc. (NASDAQ:CSBR)

Is Now The Time To Put Champions Oncology (NASDAQ:CSBR) On Your Watchlist?

Sep 28
Is Now The Time To Put Champions Oncology (NASDAQ:CSBR) On Your Watchlist?

Champions Oncology Non-GAAP EPS of -$0.02, revenue of $12.9M

Jul 21

We Think Some Shareholders May Hesitate To Increase Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Compensation

Oct 14
We Think Some Shareholders May Hesitate To Increase Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Compensation

We Think Champions Oncology (NASDAQ:CSBR) Can Afford To Drive Business Growth

Jun 21
We Think Champions Oncology (NASDAQ:CSBR) Can Afford To Drive Business Growth

Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 44%?

Apr 09
Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 44%?

Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation

Mar 19
Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation

The Champions Oncology (NASDAQ:CSBR) Share Price Has Gained 243%, So Why Not Pay It Some Attention?

Mar 02
The Champions Oncology (NASDAQ:CSBR) Share Price Has Gained 243%, So Why Not Pay It Some Attention?

Is There Now An Opportunity In Champions Oncology, Inc. (NASDAQ:CSBR)?

Feb 04
Is There Now An Opportunity In Champions Oncology, Inc. (NASDAQ:CSBR)?

Do Insiders Own Lots Of Shares In Champions Oncology, Inc. (NASDAQ:CSBR)?

Jan 14
Do Insiders Own Lots Of Shares In Champions Oncology, Inc. (NASDAQ:CSBR)?

Philip Breitfeld Is The Chief Strategy & Innovation Officer and Director of Champions Oncology, Inc. (NASDAQ:CSBR) And They Just Sold 100% Of Their Shares

Dec 19
Philip Breitfeld Is The Chief Strategy & Innovation Officer and Director of Champions Oncology, Inc. (NASDAQ:CSBR) And They Just Sold 100% Of Their Shares

Champions Oncology, Inc. (NASDAQ:CSBR) Analysts Are Pretty Bullish On The Stock After Recent Results

Dec 16
Champions Oncology, Inc. (NASDAQ:CSBR) Analysts Are Pretty Bullish On The Stock After Recent Results

Champions Oncology beats on revenue

Dec 14

Estimating The Fair Value Of Champions Oncology, Inc. (NASDAQ:CSBR)

Dec 04
Estimating The Fair Value Of Champions Oncology, Inc. (NASDAQ:CSBR)

CEO報酬分析

Champions Oncology の収益と比較して、Ronnie Morris の報酬はどのように変化したか?
日付総報酬給与会社業績
Jul 31 2024n/an/a

-US$3m

Apr 30 2024US$400kUS$400k

-US$7m

Jan 31 2024n/an/a

-US$10m

Oct 31 2023n/an/a

-US$10m

Jul 31 2023n/an/a

-US$8m

Apr 30 2023US$600kUS$400k

-US$5m

Jan 31 2023n/an/a

-US$3m

Oct 31 2022n/an/a

US$108k

Jul 31 2022n/an/a

US$401k

Apr 30 2022US$800kUS$400k

US$548k

Jan 31 2022n/an/a

US$219k

Oct 31 2021n/an/a

US$391k

Jul 31 2021n/an/a

US$115k

Apr 30 2021US$775kUS$375k

US$362k

Jan 31 2021n/an/a

-US$1m

Oct 31 2020n/an/a

-US$2m

Jul 31 2020n/an/a

-US$1m

Apr 30 2020US$1mUS$394k

-US$2m

Jan 31 2020n/an/a

-US$181k

Oct 31 2019n/an/a

-US$956k

Jul 31 2019n/an/a

-US$995k

Apr 30 2019US$146kUS$146k

US$128k

Jan 31 2019n/an/a

-US$251k

Oct 31 2018n/an/a

US$42k

Jul 31 2018n/an/a

-US$320k

Apr 30 2018US$244kn/a

-US$1m

報酬と市場: Ronnieの 総報酬 ($USD 400.00K ) は、 US市場 ($USD 649.07K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Ronnieの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Ronnie Morris (58 yo)

7.8yrs

在職期間

US$400,000

報酬

Dr. Ronnie Morris, M.D. has been Chief Executive Officer at Champions Oncology, Inc. since January 31, 2017. Dr. Morris previously served as the President and a Director of Champions Oncology, Inc. from Oc...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Ronnie Morris
CEO & Director7.8yrsUS$400.00k6.32%
$ 3.9m
David Miller
Chief Financial Officer7.5yrsUS$260.00k0.041%
$ 25.1k
Maria Mancini
Chief Operating Officer1.3yrsデータなしデータなし
Arthur Hanson
Vice President of Technology4.5yrsデータなしデータなし
Rachel Bunting
Vice President of Global Marketingno dataデータなしデータなし
Michael Ritchie
Chief Commercial Officerno dataデータなしデータなし
Karin Heidemann
Executive Vice President of Global Scientific Operations3.2yrsデータなしデータなし
Marianna Zipeto
Executive Vice President of Commercial1.3yrsデータなしデータなし

3.8yrs

平均在職期間

経験豊富な経営陣: CSBRの経営陣は 経験豊富 であると考えられます ( 3.8年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Ronnie Morris
CEO & Director14.1yrsUS$400.00k6.32%
$ 3.9m
Scott Tobin
Independent Director13.4yrsUS$93.30k0.22%
$ 136.5k
Joel Ackerman
Independent Chairman of the Board14.1yrsUS$116.62k7.08%
$ 4.4m
David Sidransky
Independent Lead Director17.3yrsUS$85.54k5.64%
$ 3.5m
René Bernards
Scientific Advisorno dataデータなしデータなし
Manuel Hidalgo
Scientific Advisorno dataデータなしデータなし
Daniel Mendelson
Independent Director11.7yrsUS$85.52k1.46%
$ 903.7k
Harvey Pass
Scientific Advisorno dataデータなしデータなし
Philip Breitfeld
Independent Director8.6yrsUS$85.54k0.11%
$ 66.6k
Misti Ushio
Board Observerno dataデータなしデータなし
Justin Stebbing
Scientific Advisorno dataデータなしデータなし
Robert Brainin
Independent Director3.8yrsUS$82.20k0%
$ 0

13.4yrs

平均在職期間

58.5yo

平均年齢

経験豊富なボード: CSBRの 取締役会 は経験豊富で 経験豊富 です ( 13.4年の平均在任期間)。